Comparing Dry Eye Prescription Drops
Side-by-side comparison of Restasis, Cequa, Xiidra, Miebo, Tyrvaya, and Eysuvis — mechanism, onset, dosing, side effects, and cost.
If over-the-counter artificial tears aren't controlling your dry eye symptoms, your doctor may recommend a prescription medication. There are now six FDA-approved options, each working through a different mechanism. Understanding how they compare helps you have an informed conversation with your doctor about which one is right for you.
Key Takeaways
- Restasis (cyclosporine 0.05%) — the original prescription dry eye drop; reduces inflammation and increases tear production over 3-6 months
- Cequa (cyclosporine 0.09%) — a higher-concentration cyclosporine with better penetration; same mechanism as Restasis
- Xiidra (lifitegrast) — targets a different inflammatory pathway; may show improvement within 2-4 weeks
- Miebo (perfluorohexyloctane) — a non-aqueous drop that directly stabilizes the tear film's oil layer; best for evaporative dry eye
- Tyrvaya (varenicline nasal spray) — the first nasal spray for dry eye; stimulates natural tear production through nerve activation
- Eysuvis (loteprednol 0.25%) — a short-term steroid for dry eye flare-ups; used for 2 weeks only
How Prescription Dry Eye Drops Work

Prescription dry eye medications fall into four categories based on their mechanism:
- Anti-inflammatory drops — Restasis, Cequa, and Xiidra reduce the chronic inflammation that drives dry eye disease. They don't just relieve symptoms — they treat the underlying cause.
- Tear film stabilizer — Miebo is a non-aqueous lipid drop that supplements the oil layer of the tear film, slowing evaporation. It works differently from all other options.
- Tear stimulator — Tyrvaya is a nasal spray that activates a nerve pathway to stimulate natural tear production from the lacrimal gland.
- Short-term steroid — Eysuvis (a low-dose loteprednol) rapidly reduces inflammation during flare-ups but is not for long-term use.
Head-to-Head Comparison
| Feature | Restasis | Cequa | Xiidra | Miebo | Tyrvaya | Eysuvis |
|---|---|---|---|---|---|---|
| Generic name | Cyclosporine 0.05% | Cyclosporine 0.09% | Lifitegrast 5% | Perfluorohexyloctane | Varenicline 0.03 mg | Loteprednol 0.25% |
| Drug class | Calcineurin inhibitor | Calcineurin inhibitor | LFA-1 antagonist | Semifluorinated alkane | Nicotinic agonist | Corticosteroid |
| Mechanism | Reduces T-cell inflammation | Reduces T-cell inflammation | Blocks LFA-1/ICAM-1 inflammation | Stabilizes tear lipid layer | Stimulates basal tear secretion | Suppresses broad inflammation |
| Delivery | Eye drop | Eye drop | Eye drop | Eye drop | Nasal spray | Eye drop |
| Dosing | Twice daily | Twice daily | Twice daily | Four times daily | Twice daily (one spray per nostril) | Four times daily for 2 weeks |
| Onset of improvement | 3-6 months | 3-6 months | 2-12 weeks | 1-4 weeks | 1-2 weeks | Days |
| Common side effects | Burning/stinging on instillation | Burning/stinging, dysgeusia | Dysgeusia (altered taste), irritation | Blurred vision (brief) | Sneezing, cough, throat irritation | Elevated IOP (rare at this dose) |
| Contact lens use | Remove before; reinsert 15 min after | Remove before; reinsert 15 min after | Remove before; reinsert 15 min after | Remove before; reinsert 15 min after | No restriction (nasal spray) | Remove before; reinsert 15 min after |
| Approximate cost tier | $$$ (generics available) | $$$$ | $$$$ | $$$$ | $$$ | $$$ |
| Duration of use | Long-term | Long-term | Long-term | Long-term | Long-term | Short-term (2 weeks) |
Choosing the Right Prescription
The best prescription depends on your type of dry eye, how quickly you need relief, and your tolerance for different side effects.
If Your Primary Problem Is Inflammation
Most dry eye involves chronic inflammation. Anti-inflammatory drops are the mainstay:
- Restasis — well-established, now available as generic cyclosporine 0.05%; most insurance-friendly option
- Cequa — higher concentration with nanomicellar technology for better penetration; may be tried if Restasis is insufficient
- Xiidra — works through a different pathway (LFA-1/ICAM-1); reasonable first choice or alternative if cyclosporine causes too much burning
If Your Primary Problem Is Tear Evaporation
When MGD causes rapid evaporation:
- Miebo — the only drop that directly targets the lipid layer; does not sting on instillation; particularly suited for evaporative dry eye
- Combine with warm compresses and lid hygiene for comprehensive MGD management
If You Can't Tolerate Eye Drops
Some patients dislike or can't tolerate drops of any kind:
- Tyrvaya — delivered as a nasal spray, completely bypassing the eye; works by stimulating the trigeminal nerve to increase natural tear production
If You're Having a Flare-Up
When symptoms suddenly worsen:
- Eysuvis — a short-term (2-week) steroid pulse to rapidly control inflammation; often used to "bridge" while a long-term medication builds its effect
Combination Approaches
Many patients benefit from combining treatments:
- An anti-inflammatory drop (Restasis, Cequa, or Xiidra) plus Miebo for combined anti-inflammatory and lipid support
- An anti-inflammatory drop plus OTC artificial tears for immediate comfort while the Rx builds effect
- Eysuvis as a 2-week bridge plus starting a long-term anti-inflammatory drop simultaneously
Many patients combine prescription and OTC drops. Artificial tears provide immediate moisture, while prescription drops work on the underlying disease. Use artificial tears as needed for comfort and your prescription drop on its scheduled twice-daily basis. Just separate them by 5-10 minutes.
What to Expect When Starting a Prescription
Adjustment Period
- Stinging or burning is common with Restasis, Cequa, and Xiidra, especially during the first few weeks. This usually improves as the eye surface heals.
- Refrigerating cyclosporine drops can reduce stinging.
- Dysgeusia (altered taste) occurs in some Xiidra and Cequa patients — usually a metallic or unusual taste shortly after instillation.
- Sneezing is common with Tyrvaya when first starting.
When to Reassess
- If burning from cyclosporine drops is intolerable after 2-3 weeks, discuss switching to Xiidra or Tyrvaya
- If you see no improvement after 3 months on Xiidra, discuss Restasis/Cequa or adding Miebo
- If you see no improvement after 6 months on any regimen, ask about combination therapy or in-office procedures like punctal plugs
Don't stop early. Anti-inflammatory drops (Restasis, Cequa, Xiidra) build their effect over weeks to months. Stopping too soon is the most common reason patients feel a prescription "didn't work." If side effects are tolerable, give the medication its full trial period before switching.
Frequently Asked Questions
What's the difference between Restasis and Xiidra?
Both reduce inflammation but through different mechanisms. Restasis (cyclosporine) is a calcineurin inhibitor that suppresses T-cell activation. Xiidra (lifitegrast) blocks the LFA-1/ICAM-1 interaction. Xiidra may work faster (weeks vs months), while Restasis has a longer track record. Some patients respond better to one than the other, and they can be combined in refractory cases.
Can I use Restasis and Xiidra together?
Yes, though this is typically reserved for moderate to severe cases that don't respond to a single agent. Some doctors prescribe one in the morning and the other in the evening. Discuss this with your ophthalmologist.
What's the difference between Cequa and Restasis?
Both contain cyclosporine. Cequa uses nanomicellar technology to deliver a higher concentration (0.09% vs 0.05%) with potentially better tissue penetration. Cequa may be tried when Restasis alone provides incomplete relief.
Is Miebo better than Xiidra?
They treat different aspects of dry eye. Miebo stabilizes the lipid layer (best for evaporative/MGD-related dry eye), while Xiidra reduces inflammation. They're not interchangeable — the choice depends on your type of dryness. They can also be combined.
How does a nasal spray treat dry eyes?
Tyrvaya (varenicline) activates the trigeminal nerve in the nasal passages, which triggers the lacrimal gland to produce natural tears. It's based on the same reflex pathway that makes your eyes water when you smell something strong.
Can I use artificial tears with my prescription drops?
Absolutely. Artificial tears provide immediate comfort while your prescription works on the underlying disease. Use them as needed for symptom relief. Just wait 5-10 minutes between different drops.
How long do I need to stay on prescription dry eye drops?
Most patients use anti-inflammatory drops (Restasis, Cequa, Xiidra) long-term — often indefinitely. Dry eye is a chronic condition, and stopping the medication typically causes symptoms to return. Your doctor may reduce frequency over time if your eye surface stabilizes.
Will insurance cover these medications?
Coverage varies widely. Generic cyclosporine (Restasis equivalent) is the most commonly covered option. Many brand-name drops require prior authorization or step therapy (trying a less expensive option first). Manufacturer copay cards and patient assistance programs can help reduce out-of-pocket costs — ask your doctor or pharmacist.
References
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Prescription medications should only be used under the supervision of a qualified healthcare provider.
Sources:
- American Academy of Ophthalmology. Dry Eye Preferred Practice Pattern.
- Jones L, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017;15(3):575-628.
- Restasis (cyclosporine ophthalmic emulsion) [prescribing information]. Allergan, Inc.
- Xiidra (lifitegrast ophthalmic solution) [prescribing information]. Novartis Pharmaceuticals.
- Cequa (cyclosporine ophthalmic solution) [prescribing information]. Sun Pharmaceutical Industries.
- Miebo (perfluorohexyloctane ophthalmic solution) [prescribing information]. Bausch + Lomb.
- Tyrvaya (varenicline nasal spray) [prescribing information]. Viatris Inc.
- Eysuvis (loteprednol etabonate ophthalmic suspension) [prescribing information]. Kala Pharmaceuticals.
